Predictors of Clinical Response to Intravenous Secukinumab Among Patients with PsA: A Post Hoc Analysis of a Phase 3 Trial

被引：0
|
作者：
Kivitz, Alan [1 ]
Sedova, Liliana [2 ,3 ]
Churchill, Melvin [4 ]
Vizcaya, Cynthia [5 ]
Sutariya, Reema [6 ]
Cao, Wenhao [6 ]
Singhal, Atul [7 ]
机构：
[1] Altoona Ctr Clin Res, Duncansville, PA USA
[2] Inst Rheumatol, Prague, Czech Republic
[3] Charles Univ Prague, Clin Rheumatol, Fac Med 1, Prague, Czech Republic
[4] Arthrit Ctr Nebraska, Lincoln, NE USA
[5] Novartis Pharma AG, Basel, Switzerland
[6] Novartis Pharmaceut, E Hanover, NJ USA
[7] Southwest Arthrit Res Grp, Mesquite, TX USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2354
引用
收藏
页码：4750 / 4752
页数：3
相关论文
共 50 条
  • [31] Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme
    Raine, Tim
    Ishiguro, Yoh
    Rubin, David T.
    Finney-Hayward, Tricia
    Vladea, Ramona
    Liu, John
    Phillips, Charles
    Cheng, Erica
    Targownik, Laura
    Loftus Jr, Edward, V
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (05): : 695 - 707
  • [32] Magnetic resonance imaging characteristics in patients with spondyloarthritis and clinical diagnosis of heel enthesitis: post hoc analysis from the phase 3 ACHILLES trial
    X. Baraliakos
    P. Sewerin
    E. de Miguel
    E. Pournara
    C. Kleinmond
    A. Shekhawat
    C. Jentzsch
    A. Wiedon
    F. Behrens
    Arthritis Research & Therapy, 24
  • [33] Post hoc analysis of clinical characteristics of patients with radiographic progression in a Japanese phase 3 trial of peficitinib and methotrexate treatment (RAJ4)
    Tanaka, Yoshiya
    Takeuchi, Tsutomu
    Kato, Daisuke
    Kaneko, Yuichiro
    Fukuda, Musashi
    Izutsu, Hiroyuki
    Rokuda, Mitsuhiro
    van der Heijde, Desiree
    MODERN RHEUMATOLOGY, 2023, 33 (01) : 73 - 80
  • [34] Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: A post hoc analysis of EXCEED
    Kaeley, Gurjit S.
    Schett, Georg
    Conaghan, Philip G.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB54 - AB54
  • [35] Lapses in Care Among Patients Assigned to Ranibizumab for Proliferative Diabetic Retinopathy A Post Hoc Analysis of a Randomized Clinical Trial
    Maguire, Maureen G.
    Liu, Danni
    Bressler, Susan B.
    Friedman, Scott M.
    Melia, Michele
    Stockdale, Cynthia R.
    Glassman, Adam R.
    Sun, Jennifer K.
    JAMA OPHTHALMOLOGY, 2021, 139 (12) : 1266 - 1273
  • [36] Efficacy and Safety of Galcanezumab as a Preventive Treatment for Episodic Migraine in South Korean Patients: A Post-Hoc Analysis of a Phase 3 Clinical Trial
    Kim, Byung-Kun
    Cho, Soo-Jin
    Han, Jeong Hee
    Dell'Agnello, Grazia
    Panni, Tommaso
    Kim, Manho
    Oh, Kyungmi
    Moon, Heui-Soo
    Chu, Min Kyung
    JOURNAL OF CLINICAL NEUROLOGY, 2023, 19 (05): : 483 - 494
  • [37] Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data
    Francois, Clement
    Hauser, Robert A.
    Aballea, Samuel
    Dorey, Julie
    Kharitonova, Elizaveta
    Hewitt, L. Arthur
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (05) : 515 - 525
  • [38] Ospemifene's effects on lipids and coagulation factors: a post hoc analysis of phase 2 and 3 clinical trial data
    Archer, David F.
    Altomare, Corrado
    Jiang, Wei
    Cort, Susannah
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2017, 24 (10): : 1167 - 1174
  • [39] Maintenance of response to brodalumab at 52 weeks among patients with moderate-to-severe psoriasis: Post hoc analysis of two phase 3 studies
    Strober, Bruce
    Armstrong, April
    Tyring, Stephen
    Papp, Kim A.
    Rastogi, Shipra
    Pillai, Radhakrishnan
    Israel, Robert J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB185 - AB185
  • [40] Predictors of poor response to urate-lowering therapy in patients with gout and hyperuricemia: a post-hoc analysis of a multicenter randomized trial
    Zepeng Mu
    Wei Wang
    Jing Wang
    Wenshan Lv
    Ying Chen
    Fang Wang
    Xiaolong Yu
    Yangang Wang
    Bingfei Cheng
    Zhongchao Wang
    Clinical Rheumatology, 2019, 38 : 3511 - 3519
12345